🔗 Share this article

Chancellor Reeves has announced she is preparing "specific steps to deal with cost of living pressures" in the forthcoming financial statement.

In comments to media outlets, she emphasized that curbing price rises is a joint task of both the government and the Bank of England.

The UK's inflation rate is expected to be the highest among the G7 developed nations this year and next.

Potential Utility Bill Interventions

It is understood the government could take action to reduce utility costs, for example by cutting the present 5% level of value-added tax applied on energy.

A further possibility is to lower some of the regulatory levies presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such actions.

The expectation from most economists is that the Chancellor will have to introduce tax increases or expenditure reductions in order to adhere to her voluntary borrowing rules.

Previously on the same day, estimates showed there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of projections.

"It is a shared responsibility between the central bank and the government to further reduce some of the drivers of price increases," the Chancellor told reporters in Washington, at the conferences of the IMF and global financial institution.

Revenue Pledges and International Issues

While much of the focus has been on expected tax increases, the chancellor said the latest figures from the OBR had not altered her commitment to campaign commitments not to increase tax levels on income tax, sales tax or National Insurance.

She attributed an "uncertain global environment" with increasing international and trade tensions for the fiscal tax moves, likely to be focused on those "most able to pay."

International Trade Disputes

Addressing worries about the United Kingdom's trade ties with China she said: "The UK's security interests always are paramount."

Recent announcement by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are crucial for high-technology manufacturing led American leader Donald Trump to suggest an extra 100% tariff on goods from China, increasing the possibility of an full-scale trade war between the two global powers.

The American finance chief labeled the Chinese move "economic coercion" and "a global supply chain control attempt."

Questioned on considering the US offer to participate in its battle with China, Reeves said she was "very concerned" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the move was "bad for the international commerce and generates further obstacles."

"It is my opinion there are sectors where we should confront Chinese policies, but there are also significant opportunities to sell into China's economy, including financial services and other sectors of the economic system. We've got to maintain that equilibrium right."

The chancellor also confirmed she was cooperating with international partners "regarding our own critical minerals plan, so that we are less reliant."

Health Service Drug Costs and Investment

The Chancellor also recognized that the cost the NHS pays for medicines could rise as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning projects in the United Kingdom, with some blaming the modest returns they are obtaining.

Recently, the Science Minister said the price the health service spends on medicines would need to increase to stop businesses and drug research funding leaving the UK.

Reeves stated to the BBC: "It has been observed as a result of the pricing regime, that drug testing, new drugs have not been available in the UK in the extent that they are in other European countries."

"We want to guarantee that people getting care from the National Health Service are able to receive the finest essential drugs in the globe. And so we are reviewing these issues, and... looking to attract more funding into Britain."